… Papillary thyroid carcinoma is the most common endocrine cancer, and its incidence is …
has been put on molecular markers involved in tumorigenesis of thyroid carcinoma with a focus …

The prognostic role of molecular markers in papillary thyroid carcinoma (PTC) is a matter of
ongoing debate. The aim of our study is to investigate the impact of RAS , BRAF , TERT …

… of papillary thyroid carcinoma (PTC), the most common type of thyroid cancer (17). It … of
expression of thyroid differentiation markers such as thyroglobulin, thyroid peroxidase, and …

… Next, we describe BRAF mutations and other molecular events occurring early in the thyroid
neoplastic transformation in the context of their relationship to thyroid cancer prognosis. …

… thyroid carcinomas. These represent the most common genetic alterations in thyroid cancer,
as well as molecular markers … The use of these and other emerging molecular markers will …

… The molecular markers we and others have identified as being significantly altered in … ATC
and DTC tumors for a panel of 63 molecular markers, we have identified alterations in a broad …

… of thyroid nodules. 1, 2 Before the era of molecular testing, diagnostic thyroid lobectomy
was recommended for many Bethesda III and all Bethesda IV thyroid nodules, which harbor …

… Poorly differentiated and anaplastic thyroid carcinomas can … The guidelines indicate that
the use of molecular markers, … improved by adding other molecular markers such as miRNA …

… anaplastic and poorly differentiated thyroid carcinomas arising from papillary carcinoma. , 20
… The accumulation of knowledge on diagnostic use of molecular markers has been reflected …

… papillary thyroid carcinoma (PTC), the most frequent thyroid malignancy. However, an increased
risk of PTC is seen in patients with goitre or thyroid … with the molecular markers of PTC. …